Pembrolizumab Retreatment: Lessons from a Selected Group of Patients with Urothelial Carcinoma

被引：0
|
作者：
Zugman, Miguel [1 ]
Nguyen, Charles B. [1 ]
机构：
[1] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA
来源：
EUROPEAN UROLOGY | 2025年 / 87卷 / 04期
关键词：
D O I：
10.1016/j.eururo.2025.01.002
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：396 / 397
页数：2
相关论文
共 50 条
  • [1] Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy
    Koshkin, Vadim S.
    Danchaivijitr, Pongwut
    Bae, Woo Kyun
    Semenov, Andrey
    Ozyilkan, Ozgur
    Su, Yu-Li
    Arija, Jose A. Arranz
    Hata, Masao Tsuji
    Bogemann, Martin
    Hendriks, Mathijs P.
    Delgado, Silvia Neciosup
    Rosenbaum, Eli
    Lopez, Karla Alejandra
    Bavle, Abhishek
    Liu, Chih-Chin
    Imai, Kentaro
    Furka, Andrea
    EUROPEAN UROLOGY, 2025, 87 (04) : 390 - 395
  • [2] Effectiveness of pembrolizumab in patients with urothelial carcinoma inhibitors
    Fukuokaya, Wataru
    Kimura, Takahiro
    Komura, Kazumasa
    Uchimoto, Taizo
    Nishimura, Kazuki
    Yanagisawa, Takafumi
    Imai, Yu
    Iwatani, Kosuke
    Ito, Kagenori
    Urabe, Fumihiko
    Tsuzuki, Shunsuke
    Kimura, Shoji
    Terada, Naoki
    Mukai, Shoichiro
    Oyama, Yu
    Abe, Hirokazu
    Kamoto, Toshiyuki
    Azuma, Haruhito
    Miki, Jun
    Egawa, Shin
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (07) : 346.e1 - 346.e8
  • [3] Pembrolizumab for Advanced Urothelial Carcinoma
    Liang, Fei
    Zhu, Ji
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23): : 2302 - 2302
  • [4] Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma
    Inokuchi, Junichi
    Eto, Masatoshi
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4519 - 4528
  • [5] Pembrolizumab for Advanced Urothelial Carcinoma Reply
    Bellmunt, Joaquim
    Bajorin, Dean F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23): : 2304 - 2304
  • [6] Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma
    Wataru Fukuokaya
    Takafumi Yanagisawa
    Masaki Hashimoto
    Shutaro Yamamoto
    Yuhei Koike
    Yu Imai
    Kosuke Iwatani
    Hajime Onuma
    Kagenori Ito
    Fumihiko Urabe
    Shunsuke Tsuzuki
    Shoji Kimura
    Jun Miki
    Yu Oyama
    Hirokazu Abe
    Takahiro Kimura
    Cancer Immunology, Immunotherapy, 2023, 72 : 841 - 849
  • [7] Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma
    Fukuokaya, Wataru
    Yanagisawa, Takafumi
    Hashimoto, Masaki
    Yamamoto, Shutaro
    Koike, Yuhei
    Imai, Yu
    Iwatani, Kosuke
    Onuma, Hajime
    Ito, Kagenori
    Urabe, Fumihiko
    Tsuzuki, Shunsuke
    Kimura, Shoji
    Miki, Jun
    Oyama, Yu
    Abe, Hirokazu
    Kimura, Takahiro
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (04) : 841 - 849
  • [8] Hyperprogression after pembrolizumab treatment in two patients with metastatic urothelial carcinoma
    Hatano, Takashi
    Matsu-ura, Taishi
    Mori, Kei-ichiro
    Inaba, Hiroyuki
    Endo, Katsuhisa
    Tamari, Mayumi
    Egawa, Shin
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (05) : 473 - 476
  • [9] Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study
    Minato, Akinori
    Furubayashi, Nobuki
    Harada, Mirii
    Negishi, Takahito
    Sakamoto, Naotaka
    Song, Yoohyun
    Hori, Yoshifumi
    Tomoda, Toshihisa
    Tamura, Shingo
    Kuroiwa, Kentaro
    Seki, Narihito
    Tomisaki, Ikko
    Harada, Kenichi
    Nakamura, Motonobu
    Fujimoto, Naohiro
    CLINICAL GENITOURINARY CANCER, 2022, 20 (05) : 499.e1 - 499.e8
  • [10] Effect of Antacids on the Survival of Patients With Metastatic Urothelial Carcinoma Treated With Pembrolizumab
    Sekito, Takanori
    Bekku, Kensuke
    Katayama, Satoshi
    Watanabe, Tomofumi
    Tsuboi, Ichiro
    Yoshinaga, Kasumi
    Maruyama, Yuki
    Yamanoi, Tomoaki
    Kawada, Tatsushi
    Tominaga, Yusuke
    Sadahira, Takuya
    Iwata, Takehiro
    Nishimura, Shingo
    Kusumi, Norihiro
    Edamura, Kohei
    Kobayashi, Tomoko
    Kurose, Kyohei
    Ichikawa, Takaharu
    Miyaji, Yoshiyuki
    Wada, Koichiro
    Kobayashi, Yasuyuki
    Araki, Motoo
    CLINICAL GENITOURINARY CANCER, 2024, 22 (04)
12345